COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit Psychedelics Investing
Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
Awakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis Technology to Conduct Feasibility Studies to Improve Differentiation of Its MDMA Program Company News
Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference Psychedelics Investing
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History Psychedelics Investing
Love Pharma's Investment in US Biotech Offers Strategic Industry Advantages and Enhanced Shareholder Value Pharmaceutical Investing
Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds Psychedelics Investing
